Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

BME:ROVI Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	46.11	27.19	25.32	124.95	99.04	53.16
Short-Term Investments	1.58	0.83	0.11	0.09	0.1	0.07
Cash & Short-Term Investments	47.69	28.02	25.44	125.03	99.14	53.23
Cash Growth	5.71%	10.15%	-79.66%	26.13%	86.22%	-21.14%
Accounts Receivable	124.28	114.83	124.55	160.23	129.8	63.34
Other Receivables	10.02	12.61	15.91	21.06	27.83	18.61
Receivables	134.29	127.44	140.46	181.28	157.63	81.95
Inventory	327.67	329.95	337.97	311.94	245.47	227.2
Prepaid Expenses	4.65	2.69	2.73	2.03	1.79	0.01
Other Current Assets	2	1.51	2.74	2.79	2.33	2.18
Total Current Assets	516.31	489.61	509.33	623.07	506.36	364.58
Property, Plant & Equipment	294.25	286.62	253.65	215.54	181.78	155.4
Long-Term Investments	19.04	19.52	0.59	2.2	2.07	1.88
Other Intangible Assets	27.52	28.23	27.74	29.14	31.51	33.93
Long-Term Deferred Tax Assets	4.23	2.26	2.34	2.08	3.85	11.11
Long-Term Deferred Charges	5.5	5.72	6.16	6.6	7.05	7.49
Other Long-Term Assets	0.07	0.07	0.07	0.07	0.07	0.07
Total Assets	869.61	832.02	799.88	878.7	732.68	574.44
Accounts Payable	57.21	89.93	109.89	125.87	99.4	65.19
Accrued Expenses	30.68	33.19	28.83	31.67	24.6	23.85
Current Portion of Long-Term Debt	27.94	17.84	8.06	8.27	2.98	2.95
Current Portion of Leases	-	5.85	5.13	4.46	3.44	3.07
Current Income Taxes Payable	6.78	2.38	5.26	-	0.68	-
Current Unearned Revenue	3.31	5.25	39.51	115.39	58.12	25.5
Other Current Liabilities	60.6	2.21	3.17	8.23	1.17	2.33
Total Current Liabilities	186.51	156.65	199.84	293.89	190.39	122.89
Long-Term Debt	101.36	80.5	38.58	46.04	52.52	53.94
Long-Term Leases	-	10.22	13.67	13.4	14.22	14.48
Long-Term Unearned Revenue	6.02	2.75	2.79	3.32	3.79	8.5
Long-Term Deferred Tax Liabilities	0.82	0.37	1.52	0.68	0.78	0.93
Total Liabilities	294.89	250.48	256.39	357.32	261.7	200.74
Common Stock	3.07	3.07	3.24	3.24	3.36	3.36
Additional Paid-In Capital	87.64	87.64	87.64	87.64	87.64	87.64
Retained Earnings	477.58	486.89	556.21	456.7	446.1	302.89
Treasury Stock	-4.61	-5.55	-107.68	-27.56	-66.12	-20.19
Comprehensive Income & Other	-0.04	-0.02	-0.02	-0.01	-0	-0
Total Common Equity	563.63	572.03	539.39	520.01	470.98	373.7
Minority Interest	11.08	9.51	4.11	1.37	-	-
Shareholders' Equity	574.72	581.54	543.49	521.38	470.98	373.7
Total Liabilities & Equity	869.61	832.02	799.88	878.7	732.68	574.44
Total Debt	129.3	114.41	65.43	72.17	73.16	74.44
Net Cash (Debt)	-81.61	-86.39	-39.99	52.87	25.97	-21.21
Net Cash Growth	-	-	-	103.55%	-	-
Net Cash Per Share	-1.60	-1.69	-0.75	0.99	0.47	-0.38
Filing Date Shares Outstanding	51.15	51.15	51.82	53.37	54.85	55.4
Total Common Shares Outstanding	51.15	51.15	51.82	53.37	54.85	55.4
Working Capital	329.79	332.96	309.49	329.19	315.97	241.69
Book Value Per Share	11.02	11.18	10.41	9.74	8.59	6.75
Tangible Book Value	533.41	543.8	511.65	490.87	439.46	339.77
Tangible Book Value Per Share	10.43	10.63	9.87	9.20	8.01	6.13
Land	75.91	74.8	60.65	45.12	37.25	35.75
Machinery	413.65	404.19	372.97	303.78	275.44	250.22
Construction In Progress	14.68	11.01	8.47	40.17	28.06	14.68

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.